CACICOL® belongs to the REGENERATING AGENT family (or RGTA). These agents are used for MATRIX THERAPY (or corneal matrix repair therapy).

CACICOL® triggers REGENERATION of damaged tissues for ENHANCED HEALING and makes it possible to DELAY OR AVOID a more invasive surgical procedure.

CACICOL® is intended for the management of chronic corneal wound healing, such as persistent epithelial defects and persistent corneal dystrophies with associated pain.

CACICOL® should be used with a medical prescription.

This medical device CACICOL® is a regulated healthcare product which, in compliance with the relevant legislation, bears CE marking. The pharmaceutical company Théa has carried out scientific studies to develop CACICOL®.

Each box of CACICOL® contains 5 detachable and ready-to-use single-dose units. CACICOL® is a preservative-free solution and has to be stored at a room temperature (between 4°C and 25°C).

The recommended dosage regimen of CACICOL® is 1 TO 2 DROPS ONCE A WEEK.


Ask your ophthalmologist if you have any questions

The mechanism of action of Cacicol

Cacicol® acts as a scaffold. Its matrix structure permits the fixation and the protection of the components involved in the tissue regeneration process.

the mechanism of action of cacicol